Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with...
Inspire Medical Systems director Michael H. Carrel files initial beneficial ownership statement
Inspire Medical Systems appoints AtriCure CEO Michael Carrel to board
Inspire Medical appoints Michael H. Carrel to Board, joins two committees
Casey Tansey to Retire from Inspire's Board, Effective July 30, 2026
Inspire Medical Systems (NYSE:INSP) Price Target Raised to $54.00
RBC Capital Reaffirms Their Hold Rating on Inspire Medical Systems (INSP)